+ 7.36
+ 2.33%
+ 2.46
+ 0.8%
+ 5.16
+ 1.36%
+ 0.15
+ 0.1%
+ 2.84
+ 1.65%

Believe It: Brexit Isn't All Bad For U.K. ETFs

July 11, 2016 8:41 am
Share to Linkedin Share to Twitter Share to Facebook Share to Print License More
Believe It: Brexit Isn't All Bad For U.K. ETFs

The Guggenheim CurrencyShares British (NYSE: FXB) is down 10.7 percent over the past month — meaning FXB, which tracks the pound's move against the U.S. dollar, is in a correction. The iShares MSCI United Kingdom ETF (iShares Trust (NYSE: EWU)) is off 7.7 percent over the same period, which means anticipation of Brexit and the subsequent outcome have been a drag on U.K. equities and the sterling.

Looking at this performances, it is easy for investors to get nervous and think that avoiding U.K. stocks and the likes of EWU is the proper course of action. Actually, the opposite could prove to be true.

A Different Perspective

Astute investors realize at least two things. First, many of the FTSE 100's biggest names, plenty of which are also found among EWU's 113 holdings, generate half or more of their revenue outside of the U.K. That says the weaker pound is good for those firms. Second, EWU is up 7 percent since its June 27 bottom.

Related Link: Post-Brexit, Save Over $100 Daily On A Visit To London

“Although the precipitous drop in the pound sounds bad, it might actually help the British economy over the long term by acting as a shock absorber to help the economy rebound. We’ve already started to see this effect in the FTSE 100, the index with the 100 largest companies listed on the London Stock Exchange, which has rebounded strongly since the news,” said BlackRock in a recent note.


A quick look at EWU's top 10 holdings, a group that combines for over 40 percent of the ETF's weight, underscores the ETF's leverage to a weaker pound. That group includes pharmaceuticals giants GlaxoSmithKline plc (ADR) (NYSE: GSK) and AstraZeneca plc (ADR)(NYSE: AZN) and oil behemoths Royal Dutch Shell plc (ADR) (NYSE: RDS-A) and BP plc (ADR) (NYSE: BP). Those are just four examples, but each of those companies depend on ex-U.K. markets for the bulk of their revenue.

How Minimal Is $5+ Million?

Still, investors appear pensive, as EWU has lost $5.86 million since the Brexit outcome was absorbed by global financial markets. Then again, less than $6 million on the back of an event like Brexit for a $1.94 billion ETF like EWU is minimal damage.

“As the pound weakens, British products look cheaper to consumers buying items using other currencies. U.K. firms are already dominant in a number of global industries like machinery, pharmaceuticals and precious stones, so firms in the rest of the world in these sectors will have to cut prices or work harder to acquire business, since British prices will become more affordable for international consumers,” according to BlackRock.

Did you like this article? Could it have been improved? Please email feedback@benzinga.com to let us know!

Related Articles

These Currency Hedged ETFs Could Enjoy 2016

3 ETFs For AstraZeneca's $39B Alexion Pharmaceuticals Takeover

The biotechnology space is always fertile territory for mergers and acquisitions, and that theme was on display over the weekend when AstraZeneca (NYSE: AZN) announced a read more

Wall Street Analysts See These 4 Stocks As Winners Moving Into December

The advancements with COVID-19 vaccines of Pfizer Inc. (NYSE: PFE), Moderna Inc. (NASDAQ: MRNA), and AstraZeneca Inc. (NASDAQ: read more

Benzinga's Bulls And Bears Of The Week: AstraZeneca, Disney, Ford, GE, Roku And More

AstraZeneca HQ and research center in Cambridge, United Kingdom read more